Deccan Health Care has informed that existing Warrant Holder (Person Other than the Promoter and Promoter Group) has exercised his right for conversion of warrants into equity shares. Pursuant to the provisions of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Warrant Holder had paid 25% (Rs. 7.5/- per warrant) of the issue price of the warrant as the warrant subscription price. The balance 75% (Rs.22.5/- per warrant) of the issue price of warrants was to be paid at the time of exercise of option to apply for fully paid - up Equity shares of Re. 10/- each of the Company, against each such warrants held by the warrant holder. In view of above and upon receipt from the warrant holder (M/s Krishna Ventures), the written notice and balance 75% (at the rate of Rs. 22.5/- per warrant) for 8,32,000 warrants for aggregating to Rs. 1,87,20,000/-, the Board of Directors of the Company at their meeting held on today , 21 December 2024 has allotted 8,32,000 equity shares of face value of Rs. 10each (Premium of Rs. 20 per equity share) pursuant to exercise of 8,32,000 convertible warrants. Consequent to this conversion of warrants/allotment of Equity Shares, 3,083,333 warrants remain pending for conversion and these warrant holders are entitled to get their warrants converted into Equity Shares of the Company by paying remaining 75%; Rs. 22.5 per warrant within 18 months from the date of warrant allotment. A list of allottees along with name of warrant holders whose warrants are pending for conversion is enclosed as Annexure-I. Pursuant to present conversion, the Issued, Subscribed and Paid-up Equity Share Capital of the Company stands increased to Rs. 22,66,58,470 consisting of 2,26,65,847 fully paid-up Equity Shares of Rs. 10each from 21,83,38,470 consisting of 2,18,33,847 fully paid-up Equity Shares of Rs. 10 each.
The above information is a part of company’s filings submitted to BSE.